Kexing Biopharm participated in CPHI Milan 2026, held from October 6 to 8, presenting its global innovative drug pipeline, biosimilars developed through collaborative partnerships, and a diverse range of medicines …
NS Pharma, Inc., headquartered in Paramus, New Jersey, has announced that its parent organization, Nippon Shinyaku Co., Ltd. of Kyoto, Japan, has signed a Sponsored Research Agreement (SRA) with Boston …
Advancing Access to Healthcare through Innovation and Partnerships Expanding access to medicines and healthcare relies on the continuous creation of evidence-driven solutions to address unmet medical needs. To support this …
Brii Biosciences Limited, a biotechnology company focused on developing treatments for diseases with significant unmet needs, announced its acquisition of intellectual property (IP) and other assets related to BRII-179 from …
Jazz Pharmaceuticals remains dedicated to its mission of developing transformative medicines for individuals with serious illnesses who have limited treatment options. By creating innovative treatments, we aim to help patients …
Many individuals facing cancer find solace and support in hearing the stories of others who have walked similar paths. Dale, currently battling breast cancer, sheds light on the significance of …
